UK consensus on normal tissue dose constraints for stereotactic radiotherapy
Six UK studies investigating stereotactic ablative radiotherapy (SABR) are currently open. Many of these involve the treatment of oligometastatic disease at different locations in the body. Members of all the trial management groups collaborated to generate a consensus document on appropriate organ...
Κύριοι συγγραφείς: | Hanna, G, Murray, L, Patel, R, Jain, S, Aitken, K, Franks, K, van As, N, Tree, A, Hatfield, P, Harrow, S, McDonald, F, Ahmed, M, Saran, F, Webster, G, Khoo, V, Landau, D, Eaton, D, Hawkins, M |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Elsevier
2017
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
UK stereotactic ablative radiotherapy trials normal tissue dose constraints tolerance consensus
ανά: Hanna, G, κ.ά.
Έκδοση: (2016) -
Stereotactic body radiotherapy for liver metastases.
ανά: Aitken, K, κ.ά.
Έκδοση: (2015) -
Stereotactic body radiotherapy for oligometastases.
ανά: Tree, A, κ.ά.
Έκδοση: (2013) -
A randomised trial of conventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
ανά: Khoo, V, κ.ά.
Έκδοση: (2018) -
CORE: A randomised trial of COnventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
ανά: Khoo, V, κ.ά.
Έκδοση: (2017)